AYURF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
Capitalization
5.6M
STEK
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
Capitalization
2.27M
Interact to see
Advertisement

AYURF vs STEK

Header iconAYURF vs STEK Comparison
Open Charts AYURF vs STEKBanner chart's image
AYURCANN
Price$0.03
Change-$0.00 (-0.00%)
Volume$10K
Capitalization5.6M
Stemtech
Price$0.01
Change-$0.00 (-0.00%)
Volume$246.84K
Capitalization2.27M
AYURF vs STEK Comparison Chart in %
Loading...
AYURF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AYURF vs. STEK commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYURF is a Hold and STEK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (AYURF: $0.03 vs. STEK: $0.01)
Brand notoriety: AYURF and STEK are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYURF: 63% vs. STEK: 101%
Market capitalization -- AYURF: $5.63M vs. STEK: $1.91M
AYURF [@Pharmaceuticals: Generic] is valued at $5.63M. STEK’s [@Pharmaceuticals: Generic] market capitalization is $1.91M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYURF’s FA Score shows that 0 FA rating(s) are green whileSTEK’s FA Score has 0 green FA rating(s).

  • AYURF’s FA Score: 0 green, 5 red.
  • STEK’s FA Score: 0 green, 5 red.
According to our system of comparison, both AYURF and STEK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYURF’s TA Score shows that 6 TA indicator(s) are bullish while STEK’s TA Score has 4 bullish TA indicator(s).

  • AYURF’s TA Score: 6 bullish, 3 bearish.
  • STEK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AYURF is a better buy in the short-term than STEK.

Price Growth

AYURF (@Pharmaceuticals: Generic) experienced а -12.42% price change this week, while STEK (@Pharmaceuticals: Generic) price change was +5.31% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.65%. For the same industry, the average monthly price growth was +25.30%, and the average quarterly price growth was +68.50%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.65% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AYURF($5.6M) has a higher market cap than STEK($2.27M). AYURF YTD gains are higher at: 78.395 vs. STEK (-66.523). AYURF (-1.61M) and STEK (-1.67M) have comparable annual earnings (EBITDA) . AYURF has more cash in the bank: 1.08M vs. STEK (272K). AYURF has less debt than STEK: AYURF (2.74M) vs STEK (4.14M). AYURF has higher revenues than STEK: AYURF (29.8M) vs STEK (3.91M).
AYURFSTEKAYURF / STEK
Capitalization5.6M2.27M247%
EBITDA-1.61M-1.67M96%
Gain YTD78.395-66.523-118%
P/E RatioN/AN/A-
Revenue29.8M3.91M762%
Total Cash1.08M272K397%
Total Debt2.74M4.14M66%
FUNDAMENTALS RATINGS
STEK: Fundamental Ratings
STEK
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AYURFSTEK
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AYURF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TEM78.481.15
+1.49%
Tempus AI Inc.
CLCO9.270.01
+0.11%
Cool Company Ltd
BANR65.15-0.07
-0.11%
Banner Corp
WOK0.08N/A
-5.23%
WORK Medical Technology Group Ltd
ABVE1.63-0.13
-7.39%
Above Food Ingredients Inc

AYURF and

Correlation & Price change

A.I.dvisor tells us that AYURF and PRFX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYURF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYURF
1D Price
Change %
AYURF100%
-12.42%
PRFX - AYURF
21%
Poorly correlated
-6.71%
HNSPF - AYURF
11%
Poorly correlated
N/A
STEK - AYURF
5%
Poorly correlated
-7.75%
BFRI - AYURF
3%
Poorly correlated
+0.02%
HLBBF - AYURF
-0%
Poorly correlated
N/A
More

STEK and

Correlation & Price change

A.I.dvisor tells us that STEK and CNADF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STEK and CNADF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STEK
1D Price
Change %
STEK100%
+18.32%
CNADF - STEK
25%
Poorly correlated
N/A
BFRI - STEK
12%
Poorly correlated
-0.02%
HLNCF - STEK
11%
Poorly correlated
-3.57%
PLSH - STEK
8%
Poorly correlated
-13.64%
EAPIF - STEK
6%
Poorly correlated
N/A
More